Apyx Medical Q1 EPS $(0.22) Misses $(0.20) Estimate, Sales $10.24M Beat $9.53M Estimate
Apyx Medical Q1 EPS $(0.22) Misses $(0.20) Estimate, Sales $10.24M Beat $9.53M Estimate
Apyx Medical第一季度每股收益（0.22）未達到預期（0.20）美元，銷售額爲1,024萬美元，超過953萬美元的預期
Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.21) by 4.76 percent. This is a 120 percent decrease over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $10.24 million which beat the analyst consensus estimate of $9.53 million by 7.49 percent. This is a 15.63 percent decrease over sales of $12.14 million the same period last year.
Apyx Medical（納斯達克股票代碼：APYX）公佈的季度虧損爲每股0.22美元，比分析師普遍預期的0.21美元（0.21美元）低4.76％。這比去年同期每股虧損0.10美元（0.10）下降了120％。該公司公佈的季度銷售額爲1,024萬美元，比分析師普遍預期的953萬美元高出7.49％。這比去年同期的1,214萬美元的銷售額下降了15.63％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。